Skip to main content

Viridian Therapeutics, Inc.

VRDN
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
SEC CIK
0001590750

In the last 90 days, Viridian Therapeutics, Inc. insiders filed 0 open-market purchases and 1 sale; 214 institutions reported holding it in 13F filings for Q2 2026, worth $2.50B in total; no superinvestor holds it.

13F holders, Q3 2024

Institutional positions in Viridian Therapeutics, Inc. as of Sep 30, 2024. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works

Institutional holders
165
+29 vs. Q2 2024
Shares held
87.0M
+22.1M (+34.0%) vs. Q2 2024
Total value
$1.98B
+$1.14B (+134.5%) vs. Q2 2024
New holders
45
65 more added
Sold out
16
41 more reduced

2 institutions that held it in Q2 2024 haven't filed for Q3 2024 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.

Compare with Q2 2024: new holders, sold out and not filed yet

Holders and value by quarter

Institutions reporting VRDN on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.

Institutional holdersQ3 2024: 165 institutions
Q1 2021: 33 institutionsQ2 2021: 26 institutionsQ3 2021: 39 institutionsQ4 2021: 55 institutionsQ1 2022: 72 institutionsQ2 2022: 84 institutionsQ3 2022: 105 institutionsQ4 2022: 122 institutionsQ1 2023: 135 institutionsQ2 2023: 128 institutionsQ3 2023: 124 institutionsQ4 2023: 132 institutionsQ1 2024: 136 institutionsQ2 2024: 138 institutionsQ3 2024: 165 institutionsQ4 2024: 179 institutionsQ1 2025: 177 institutionsQ2 2025: 171 institutionsQ3 2025: 169 institutionsQ4 2025: 229 institutionsQ1 2026: 225 institutionsQ2 2026: 214 institutions
Value heldQ3 2024: $1.98B
Q1 2021: $84.5MQ2 2021: $109.8MQ3 2021: $223.7MQ4 2021: $459.8MQ1 2022: $460.9MQ2 2022: $327.7MQ3 2022: $778.5MQ4 2022: $1.21BQ1 2023: $1.10BQ2 2023: $1.12BQ3 2023: $769.9MQ4 2023: $1.31BQ1 2024: $1.24BQ2 2024: $906.2MQ3 2024: $1.98BQ4 2024: $1.75BQ1 2025: $1.23BQ2 2025: $1.32BQ3 2025: $2.01BQ4 2025: $3.36BQ1 2026: $2.21BQ2 2026: $2.50B
Institutions holding VRDN and their total value by quarter
QuarterHoldersValue
Q2 2026214$2.50B
Q1 2026225$2.21B
Q4 2025229$3.36B
Q3 2025169$2.01B
Q2 2025171$1.32B
Q1 2025177$1.23B
Q4 2024179$1.75B
Q3 2024165$1.98B
Q2 2024138$906.2M
Q1 2024136$1.24B
Q4 2023132$1.31B
Q3 2023124$769.9M
Q2 2023128$1.12B
Q1 2023135$1.10B
Q4 2022122$1.21B
Q3 2022105$778.5M
Q2 202284$327.7M
Q1 202272$460.9M
Q4 202155$459.8M
Q3 202139$223.7M
Q2 202126$109.8M
Q1 202133$84.5M

Institutions, Q3 2024

Shares, value and share of portfolio for each institution holding Viridian Therapeutics, Inc.; share changes are against Q2 2024.

Institutions holding VRDN in Q3 2024
InstitutionSharesValue% of portfolioChange in sharesAction
Atika Capital Management LLC167,000$3.80M0.41%+167,000New
Panagora Asset Management Inc168,433$3.83M0.02%+168,433New
Bank of New York Mellon Corp170,830$3.89M0.00%−37,846−18.1%Reduced
Principal Financial Group Inc172,810$3.93M0.00%+162,665+1,603.4%Added
Exome Asset Management LLC174,400$3.97M2.68%+174,400New
Bank of America Corp180,969$4.12M0.00%−29,708−14.1%Reduced
HighVista Strategies LLC185,240$4.21M1.45%−13,244−6.7%Reduced
Hennion & Walsh Asset Management, Inc.197,401$4.49M0.21%+18,546+10.4%Added
Kopp Family Office, LLC205,737$4.68M2.98%00.0%Unchanged
Nuveen Asset Management, LLC228,385$5.20M0.00%−270,018−54.2%Reduced
Wellington Management Group LLP235,987$5.37M0.00%−48,057−16.9%Reduced
Citadel Advisors LLC241,267$5.49M0.01%+196,596+440.1%Added
Integral Health Asset Management, LLC250,000$5.69M0.67%+250,000New
Dimensional Fund Advisors LP327,080$7.44M0.00%+219,500+204.0%Added
Balyasny Asset Management LLC339,089$7.71M0.02%+339,089New
Eagle Asset Management Inc313,130$7.89M0.04%−60,332−16.2%Reduced
Jane Street Group, LLC351,153$7.99M0.01%+238,078+210.5%Added
Deutsche Bank AG379,547$8.63M0.00%+331,102+683.5%Added
Lord, Abbett & Co. LLC391,958$8.92M0.03%+391,958New
JPMorgan Chase & Co400,351$9.11M0.00%+274,641+218.5%Added
Parkman Healthcare Partners LLC425,000$9.67M1.23%+425,000New
Russell Investments Group, Ltd.442,334$10.1M0.01%+92,703+26.5%Added
Two Sigma Advisers, LP444,800$10.1M0.02%−81,900−15.5%Reduced
Two Sigma Investments, LP482,136$11.0M0.02%+62,316+14.8%Added
Fisher Asset Management, LLC494,924$11.3M0.00%+99,427+25.1%Added
Ikarian Capital, LLC499,977$11.4M3.53%+499,977New
Charles Schwab Investment Management Inc516,213$11.7M0.00%+32,292+6.7%Added
Cutter Capital Management, LP518,677$11.8M3.48%+518,677New
Affinity Asset Advisors, LLC525,000$11.9M1.85%+375,000+250.0%Added
Walleye Capital LLC560,007$12.7M0.14%+129,411+30.1%Added
Northern Trust Corp581,608$13.2M0.00%+101,727+21.2%Added
Nationale-Nederlanden Powszechne Towarzystwo Emerytalne S.A.633,090$14.4M2.00%+633,090New
Millennium Management LLC668,036$15.2M0.01%+439,854+192.8%Added
Marshall Wace, LLP684,799$15.6M0.02%+611,825+838.4%Added
Eversept Partners, LP691,232$15.7M1.21%+123,745+21.8%Added
5AM Venture Management, LLC736,595$16.8M3.46%00.0%Unchanged
Goldman Sachs Group Inc739,253$16.8M0.00%−260,688−26.1%Reduced
Candriam Luxembourg S.C.A.749,804$17.1M0.10%00.0%Unchanged
Great Point Partners LLC750,000$17.1M5.15%+250,000+50.0%Added
Schonfeld Strategic Advisors LLC763,118$17.4M0.14%+617,365+423.6%Added
Woodline Partners LP818,995$18.6M0.16%+418,080+104.3%Added
Yiheng Capital Management, L.P.847,891$19.3M3.56%−100,239−10.6%Reduced
Octagon Capital Advisors LP870,000$19.8M3.17%+250,000+40.3%Added
Morgan Stanley1,009,879$23.0M0.00%+689,309+215.0%Added
Pictet Asset Management Holding SA1,025,337$23.3M0.03%+3,233+0.3%Added
Adage Capital Partners GP, L.L.C.1,205,000$27.4M0.05%+1,205,000New
Geode Capital Management, LLC1,493,311$34.0M0.00%+81,951+5.8%Added
Vivo Capital, LLC1,678,207$38.2M3.16%00.0%Unchanged
EcoR1 Capital, LLC1,958,847$44.6M1.53%+1,958,847New
Driehaus Capital Management LLC1,991,490$45.3M0.39%+1,991,490New
Maverick Capital LtdSuperinvestorMaverick Capital1,997,153$45.4M0.89%−1,310,792−39.6%Reduced
Alliancebernstein L.P.2,202,739$50.1M0.02%+204,547+10.2%Added
Tang Capital Management LLC2,242,925$51.0M3.65%+850,000+61.0%Added
State Street Corp2,379,774$54.1M0.00%−392,605−14.2%Reduced
Novo Holdings A/S2,385,000$54.3M2.69%+385,000+19.3%Added
Kynam Capital Management, LP2,511,295$57.1M4.43%+761,295+43.5%Added
Commodore Capital LP2,550,124$58.0M3.63%+22,092+0.9%Added
Perceptive Advisors LLC2,812,665$64.0M1.37%+1,180,837+72.4%Added
Paradigm Biocapital Advisors LP2,895,689$65.9M2.31%−6600.0%Reduced
Fairmount Funds Management LLC3,445,813$78.4M6.36%+1,600,000+86.7%Added
Deep Track Capital, LP3,750,945$85.3M2.72%−172,904−4.4%Reduced
VR Adviser, LLC3,882,709$88.3M4.63%+380.0%Added
Vanguard Group Inc4,420,097$100.6M0.00%+1,074,366+32.1%Added
BlackRock, Inc.4,804,006$109.3M0.00%+4,804,006New
FMR LLC11,183,478$254.4M0.02%+1,610,130+16.8%Added
Polar Capital Holdings Plc0$00.00%−889,198−100.0%Sold out
RTW Investments, LP0$00.00%−605,816−100.0%Sold out
Rosalind Advisors, Inc.0$00.00%−300,000−100.0%Sold out
Acuta Capital Partners, LLC0$00.00%−199,433−100.0%Sold out
Alyeska Investment Group, L.P.0$00.00%−100,000−100.0%Sold out
J. Goldman & Co LP0$00.00%−74,985−100.0%Sold out
Caption Management, LLC0$00.00%−44,300−100.0%Sold out
Belvedere Trading LLC0$00.00%−28,720−100.0%Sold out
Capstone Investment Advisors, LLC0$00.00%−21,016−100.0%Sold out
Nebula Research & Development LLC0$00.00%−18,897−100.0%Sold out
Bridgefront Capital, LLC0$00.00%−15,709−100.0%Sold out
Alpine Global Management, LLC0$00.00%−13,794−100.0%Sold out
UBS Oconnor LLC0$00.00%−10,057−100.0%Sold out
EntryPoint Capital, LLC0$00.00%−5,569−100.0%Sold out
Pacer Advisors, Inc.0$00.00%−825−100.0%Sold out
Headlands Technologies LLC0$00.00%−596−100.0%Sold out
BlackRock Inc.––––Not filed
Institutional & Family Asset Management, LLC––––Not filed